Implications of baseline IgG4-to-IgG ratios for autoimmune manifestations in common variable immunodeficiency

Year 2026, Volume: 7 Issue: 1, 133 - 139, 20.02.2026

Mehmet Kılınç , Fatih Çölkesen , Recep Evcen , Filiz Sadi Aykan , Eray Yıldız , Tuğba Önalan , Fatma Arzu Akkuş , Şevket Arslan

https://izlik.org/JA29DS34CR

Abstract

Aims: This study investigated whether baseline serum IgG4-to-IgG ratios are associated with the presence of autoimmune manifestations in patients diagnosed with common variable immunodeficiency (CVID).
Methods: A retrospective cohort analysis was performed using clinical data from 85 patients with CVID evaluated between January 2013 and November 2023. The study included patients aged 18 years and over with a confirmed diagnosis of CVID. Patients with incomplete or insufficient clinical information were excluded. Serum IgG4-to-IgG ratios measured at initial assessment were compared between individuals with autoimmune manifestations and those without.
Results: Of the 85 patients, 36 (42.4%) had at least one autoimmune condition. Autoimmune cytopenias constituted the most frequent autoimmune presentation (17.6%). The median IgG4-to-IgG ratio in CVID with autoimmune disease was 0.018 (interquartile range, 0.014–0.043), which was significantly lower than that observed in the group without autoimmunity (p=0.03). Building on this finding, ROC analysis identified a threshold IgG4-to-IgG ratio of 0.04 for differentiating autoimmune from non autoimmune cases (AUC 0.709; 95% CI 0.60–0.82; p=0.002; sensitivity 72%; specificity 60%). Finally, logistic regression analysis demonstrated that a reduced IgG4-to-IgG ratio was significantly associated with the development of autoimmune disease (odds ratio, 1.682; 95% confidence interval, 1.129–2.489; p=0.037).
Conclusion: Lower baseline IgG4-to-IgG ratios were associated with autoimmune manifestations in CVID. This parameter may serve as a practical adjunctive biomarker for the early identification and monitoring of autoimmune complications in this heterogeneous disorder.

Keywords

Common variable immunodeficiency , autoimmunity , IgG4-to-IgG , immunoglobulin subclasses

Ethical Statement

The study was initiated with the approval of the Necmettin Erbakan University Medical Faculty Clinical Researches Ethics Committee (Date: 2023, Decision No: 2023/4697).

Thanks

None

References

• Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2019;123(5):454-460. doi:10.1016/j.anai.2019.07.014
• Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763-1770. doi:10.1016/j.jaip.2019.02.004
• Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38-59. doi:10.1016/j.jaip.2015.07.025
• Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency: an update. Arthritis Res Ther. 2012;14(5):223. doi:10.1186/ar4032
• Gathmann B, Mahlaoui N, Gérard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116-126. doi:10.1016/j.jaci.2013.12.1077
• Azizi G, Abolhassani H, Asgardoon MH, et al. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017;13(2):101-115. doi:10.1080/ 1744666x.2016.1224664
• Fischer A, Provot J, Jais JP, Alcais A, Mahlaoui N. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017;140(5):1388-1393.e1388. doi:10.1016/j.jaci.2016.12.978
• Maglione PJ. Autoimmune and lymphoproliferative complications of common variable immunodeficiency. Curr Allergy Asthma Rep. 2016; 16(3):19. doi:10.1007/s11882-016-0597-6
• Ho HE, Cunningham-Rundles C. Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis. Front Immunol. 2020;11:149. doi: 10.3389/fimmu.2020.00149
• Schauer U, Stemberg F, Rieger CH, et al. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem. 2003; 49(11):1924-1929. doi:10.1373/clinchem.2003.022350
• Feuille EJ, Anooshiravani N, Sullivan KE, Fuleihan RL, Cunningham-Rundles C. Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry. J Clin Immunol. 2018;38(1):28-34. doi:10.1007/s10875-017-0456-9
• Nirula A, Glaser SM, Kalled SL, Taylor FR. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol. 2011;23(1):119-124. doi:10.1097/BOR.0b013e3283412fd4
• Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy. 2009;39(4):469-477. doi:10.1111/j. 1365-2222.2009.03207.x
• Koutroumpakis F, Phillips AE, Yadav D, et al. Serum IgG4 subclass deficiency defines a distinct, commonly encountered, severe inflammatory bowel disease subtype. Inflamm Bowel Dis. 2021;27(6): 855-863. doi:10.1093/ibd/izaa230
• van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science (New York, NY). 2007;317(5844):1554-1557. doi:10. 1126/science.1144603
• Bousfiha A, Moundir A, Tangye SG, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508-1520. doi:10.1007/s10875-022-01352-z
• Sogkas G, Witte T. The link between rheumatic disorders and inborn errors of immunity. EBioMedicine. 2023;90:104501. doi:10.1016/j.ebiom. 2023.104501
• Rispens T, Huijbers MG. The unique properties of IgG4 and its roles in health and disease. Nat Rev Immunol. 2023;23(11):763-778. doi:10.1038/s41577-023-00871-z
• Seidel M, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763–1770. doi:10.1016/j.jaip.2019.02.004
• Wågström P, Hjorth M, Appelgren D, et al. Immunological characterization of IgG subclass deficiency reveals decreased Tregs and increased circulating costimulatory and regulatory immune checkpoints. Front Immunol. 2024;15:1442749. doi:10.3389/fimmu.2024. 1442749
• Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650-1657. doi:10.1182/blood-2011-09-377945
• Hill SL, Mitchell JL, Burnett D, Stockley RA. IgG subclasses in the serum and sputum from patients with bronchiectasis. Thorax. 1998;53(6):463-468. doi:10.1136/thx.53.6.463
• Moss RB, Carmack MA, Esrig S. Deficiency of IgG4 in children: association of isolated IgG4 deficiency with recurrent respiratory tract infection. J Pediatr. 1992;120(1):16-21. doi:10.1016/s0022-3476(05)80590-6
• Loh RK, Harth SC, Thong YH, Ferrante A. Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J. 1990;9(8):547-551. doi:10.1097/00006454-199008000-00004
• Kim JH, Park HJ, Choi GS, et al. Immunoglobulin G subclass deficiency is the major phenotype of primary immunodeficiency in a Korean adult cohort. J Korean Med Sci. 2010;25(6):824-828. doi:10.3346/jkms.2010.25. 6.824
• Zhang H, Li P, Wu D, et al. Serum IgG subclasses in autoimmune diseases. Medicine. 2015;94(2):e387. doi:10.1097/md.0000000000000387
• Morland C, Michael J, Adu D. IgG subclasses of PEG precipitable IgG in systemic lupus erythematosus sera. Clin Nephrol. 1989;31(4):204-209.
• Sun W, Gao RF, Chen Y, Su YY, Dong LL. Measurement of serum IgG4 levels by an established ELISA system and its clinical applications in autoimmune diseases. J Huazhong Univ Sci Technol Med Sci. 2013;33(4): 611-614. doi:10.1007/s11596-013-1167-y
• Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Int Med (Tokyo, Japan). 2002;41(11):936-942. doi:10.2169/internalmedicine.41.936
• Pan Q, Guo L, Wu J, et al. Association between IgG4 autoantibody and complement abnormalities in systemic lupus erythematosus. Mediators Inflamm. 2016;2016:2196986. doi:10.1155/2016/2196986
• Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet (London, England). 2015;385(9976):1460-1471. doi:10.1016/s0140-6736(14)60720-0
• Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):57-66. doi:10.1097/BOR.0b 013e3283418057
• Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014; 147(3):602-609. doi:10.1053/j.gastro.2014.05.036
• Wright BL, Kulis M, Guo R, et al. Food-specific IgG(4) is associated with eosinophilic esophagitis. J Allergy Clin Immunol. 2016;138(4):1190-1192.e1193. doi:10.1016/j.jaci.2016.02.024
• Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006; 101(9):2070-2075. doi:10.1111/j.1572-0241.2006.00772.x
• Bjõrnsson E, Almer S, Prytz H, Werner M, Sangfelt P, Rajani R. T1871 the prevalence of elevated IgG4 levels in patients with primary sclerosing cholangitis. Gastroenterology. 2009;136(5 Suppl 1):A854. doi:10.1016/S0016-5085(09)63939-1
• Wang Z, Zhu M, Luo C, et al. High level of IgG4 as a biomarker for a new subset of inflammatory bowel disease. Sci Rep. 2018;8(1):10018. doi:10. 1038/s41598-018-28397-8
• Zhang Y, Huang Y, Huang B, et al. Clinical evaluation of antiphospholipase A2 receptor IgG4 level and its IgG4-to-IgG ratio based on quantitative immunoassays in idiopathic membranous nephropathy. BioMed Res Int. 2022;2022:9127520. doi:10.1155/2022/9127520
• Wang W, Li Y, Feng H. The significance of serum IgG4/IgG and IgG4/IgG1 ratio in the diagnosis value of IgG4-related diseases. Discov Med. 2023;35(177):476-482. doi:10.24976/Discov.Med.202335177.48